Virtual Medicinal Product (VMP)
-
Doxorubicin (liposomal) 50mg/25ml solution for infusion vials
Name Details
Current Name
Doxorubicin (liposomal) 50mg/25ml solution for infusion vials
|
Start Date
16-01-2009
|
End Date
|
Previous Name
Doxorubicin (liposomal) 50mg/25ml solution for injection vials
|
Start Date
27-07-2004
|
End Date
15-01-2009
|
|
Abbreviated Name
Doxorubicin (liposomal) 50mg/25ml inf vials
|
Start Date
16-01-2009
|
|
Doxorubicin (liposomal) 50mg/25ml soln for inj vials |
Previous Start Date
28-07-2004
|
Previous End Date
15-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 25.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01DB01
BNF |
Previous BNF
08010200
|
Start Date
09-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
134619001 |
05-09-2003 |
|
VMP Ingredients
Name
Doxorubicin hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
No Parent VTM
-
VMP
(Current) Doxorubicin (liposomal) 50mg/25ml so...
Virtual Medicinal Product Pack (VMPP) Information